PIER4 (Tat-PIER1)

General Information


DCTPep ID  DCTPep01831

Peptide Name   PIER4 (Tat-PIER1)

Sequence  GRKKRRQRRRPQ

Sequence Length  12

UniProt ID  Not available

PubChem CID  Not available

Origin  AMPs

Type  Synthetic peptide

Classification

  

ACP Tumor active peptide Cancer targeted peptides



Activity Information


Cell Line Disease Activity Assay Testing Time Literature
SK-BR-3 Breast adenocarcinoma TAT-PIER1 dose-dependently killed a breast cancer cell line, SKBR3 Flow cytometry 12 h Patent

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Hsp90

Affinity  Not available

Mechanism  Not available



Structure Information


PDB ID  Not available

Predicted Structure  Not available

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C65H124N34O15

Absent amino acids  ACDEFHILMNSTVWY

Theoretical pI  12.70

Acidic residues  0

Basic residues  8

Polar residues  1

Molecular weight (Average)  1621.92

Molecular weight (Monoisotopic)  1621

Common amino acids  R

Net charge  8

Instability index (II)  227.68

Aliphatic index  0.00

Grand average of hydropathicity (GRAVY)  -3.650

Half Life 
  30 hours (mammalian reticulocytes, in vitro).
  >20 hours (yeast, in vivo).
  >10 hours (Escherichia coli, in vivo).

Extinction coefficients 
  Should not be visible by UV spectrophotometry.

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID WO2013/134116A1

Patent Title  Hsp90 Inhibitor for the Treatment of Cancer and Inflammatory Diseases

Other Iinformation  Patent Application; Family: 1s / 1ex; Family Jurisdictions: WO; Legal Status: Pending; Application No: 2013028852; Filed: Mar 4, 2013; Published: Sep 12, 2013; Earliest Priority: Mar 5, 2012

Other Published ID  US201261606551P20120305 




DCTPep is developed by Dr.Zheng's team.